b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30781364</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>05</Month>\n            <Day>01</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">2072-6643</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>11</Volume>\n                    <Issue>2</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Feb</Month>\n                        <Day>15</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Nutrients</Title>\n                <ISOAbbreviation>Nutrients</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>(-)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo.</ArticleTitle>\n            <ELocationID EIdType="pii" ValidYN="Y">E412</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.3390/nu11020412</ELocationID>\n            <Abstract>\n                <AbstractText>Dysregulation of epidermal growth factor receptor (EGFR)/human epidermal growth factor-2 (HER2) family is a hallmark of aggressive breast cancer. Small-molecule tyrosine kinase inhibitors are among the most effective cancer targeted treatments. (-)-Oleocanthal (OC) is a naturally occurring phenolic secoiridoid lead from extra-virgin olive oil with documented anti-cancer activities via targeting mesenchymal epithelial transition factor (c-Met). Dysregulation of c-Met promotes aggressiveness to breast cancer-targeted therapies. Lapatinib (LP) is an FDA-approved dual EGFR/HER2 inhibitor for HER2-amplified breast cancer. HER2-Positive tumor cells can escape targeted therapies like LP effects by overexpressing c-Met. Combined OC-LP treatment is hypothesized to be mechanistically synergistic against HER2-overexpressing breast cancer. Combined sub-effective treatments of OC-LP resulted in synergistic anti-proliferative effects against the HER2-positive BT-474 and SK-BR-3 breast cancer cell lines, compared to OC or LP monotherapy. Antibody array and Western blot analysis showed that combined OC-LP treatment significantly inhibited EGFR, HER2, and c-Met receptor activation, as well as multiple downstream signaling proteins, compared to individual OC or LP treatment. OC-LP Combination significantly inhibited invasion and migration of breast cancer cells through reduced activation of focal adhesion kinase (FAK) and paxillin. Combined treatment of OC-10 mg/kg with LP-12.5 mg/kg suppressed more than 90% of BT-474 tumor cells growth in a nude mouse xenograft model, compared to individual OC or LP treatment. Activated c-Met, EGFR, HER2, and protein kinase B (AKT) were significantly suppressed in combination-treated mice tumors, compared to OC or LP monotherapy. This study reveals the OC future potential as combination therapy to sensitize HER2-overexpressing breast cancers and significantly reduce required doses of targeted HER family therapeutics.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Siddique</LastName>\n                    <ForeName>Abu Bakar</ForeName>\n                    <Initials>AB</Initials>\n                    <Identifier Source="ORCID">0000-0001-5424-9475</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA. siddiqab@warhawks.ulm.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ebrahim</LastName>\n                    <ForeName>Hassan Y</ForeName>\n                    <Initials>HY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA. hassanchem.phd@outlook.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Akl</LastName>\n                    <ForeName>Mohamed R</ForeName>\n                    <Initials>MR</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA. mohamedreda_pharmacy@yahoo.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ayoub</LastName>\n                    <ForeName>Nehad M</ForeName>\n                    <Initials>NM</Initials>\n                    <Identifier Source="ORCID">0000-0003-2284-4370</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan. nmayoub@just.edu.jo.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Goda</LastName>\n                    <ForeName>Amira A</ForeName>\n                    <Initials>AA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA. amirakareem16@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mohyeldin</LastName>\n                    <ForeName>Mohamed M</ForeName>\n                    <Initials>MM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA. mohyelmm@warhawks.ulm.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Nagumalli</LastName>\n                    <ForeName>Suresh K</ForeName>\n                    <Initials>SK</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA. nagumask@warhawks.ulm.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hananeh</LastName>\n                    <ForeName>Wael M</ForeName>\n                    <Initials>WM</Initials>\n                    <Identifier Source="ORCID">0000-0002-2352-4435</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology and Public Health, Faculty of Veterinary Medicine, Jordan University of Science and Technology (JUST), Irbid 22110, Jordan. whananeh@just.edu.jo.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Liu</LastName>\n                    <ForeName>Yong-Yu</ForeName>\n                    <Initials>YY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA. yliu@ulm.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Meyer</LastName>\n                    <ForeName>Sharon A</ForeName>\n                    <Initials>SA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA. meyer@ulm.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>El Sayed</LastName>\n                    <ForeName>Khalid A</ForeName>\n                    <Initials>KA</Initials>\n                    <Identifier Source="ORCID">0000-0002-1456-4064</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA. elsayed@ulm.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>R15 CA167475</GrantID>\n                    <Acronym>CA</Acronym>\n                    <Agency>NCI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>LEQSF(2017-20)-RD-B-07)</GrantID>\n                    <Agency>Louisiana Board of Regents</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>15</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Switzerland</Country>\n            <MedlineTA>Nutrients</MedlineTA>\n            <NlmUniqueID>101521595</NlmUniqueID>\n            <ISSNLinking>2072-6643</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000447">Aldehydes</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000081004">Cyclopentane Monoterpenes</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D010636">Phenols</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0VUA21238F</RegistryNumber>\n                <NameOfSubstance UI="D000077341">Lapatinib</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>AC7QO6038O</RegistryNumber>\n                <NameOfSubstance UI="C503534">oleocanthal</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.10.1</RegistryNumber>\n                <NameOfSubstance UI="C508053">ERBB2 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.10.1</RegistryNumber>\n                <NameOfSubstance UI="D066246">ErbB Receptors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.10.1</RegistryNumber>\n                <NameOfSubstance UI="D018719">Receptor, ErbB-2</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000447" MajorTopicYN="N">Aldehydes</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000081004" MajorTopicYN="N">Cyclopentane Monoterpenes</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D058750" MajorTopicYN="N">Epithelial-Mesenchymal Transition</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D066246" MajorTopicYN="N">ErbB Receptors</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000077341" MajorTopicYN="N">Lapatinib</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010636" MajorTopicYN="N">Phenols</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018719" MajorTopicYN="N">Receptor, ErbB-2</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">(\xe2\x88\x92)-Oleocanthal</Keyword>\n            <Keyword MajorTopicYN="N">HER2/neu</Keyword>\n            <Keyword MajorTopicYN="N">breast cancer</Keyword>\n            <Keyword MajorTopicYN="N">c-Met</Keyword>\n            <Keyword MajorTopicYN="N">combination</Keyword>\n            <Keyword MajorTopicYN="N">lapatinib</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>28</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>11</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>20</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>2</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30781364</ArticleId>\n            <ArticleId IdType="pii">nu11020412</ArticleId>\n            <ArticleId IdType="doi">10.3390/nu11020412</ArticleId>\n            <ArticleId IdType="pmc">PMC6412724</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Cancer Res. 2001 Oct 1;61(19):7196-203</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11585755</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Ther. 2001 Dec;1(2):85-94</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12467226</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncologist. 2004;9 Suppl 3:10-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15163842</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2005 Sep 1;437(7055):45-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16136122</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2005 Oct 20;353(16):1652-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16236735</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2006 Feb 1;66(3):1630-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16452222</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lab Invest. 2006 Oct;86(10):981-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16924245</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2007 May 18;316(5827):1039-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17463250</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2008 Mar 1;68(5):1471-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18316611</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Ther. 2008 Aug;30(8):1426-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18803986</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2008 Nov 15;68(22):9479-87</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19010923</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Ther. 2009 May;8(5):1207-17</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19435870</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2009 Jun;9(6):400-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19440234</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12903-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19617568</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2009 Aug 20;27(24):3908-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19620495</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2009 Sep 1;69(17):6871-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19671800</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2009 Dec 15;69(24):9330-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19934333</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2010 Jan 15;70(2):440-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20068163</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Carcinog. 2011 Apr;50(4):264-79</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20648549</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Ther. 2011 Mar;10(3):518-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21252284</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Planta Med. 2011 Jul;77(10):1013-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21328179</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2011 Aug 18;30(33):3625-35</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21423210</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Obstet Gynecol. 2011 Feb;23(1):37-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21500375</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Cancer. 2011 Sep 6;105(6):807-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21847121</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res. 2011 Aug 12;13(4):215</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21884641</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res. 2011;13(6):R121</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22123186</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Clin Oncol. 2011 Nov 29;9(1):16-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22124364</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Ther. 2012 Mar;11(3):660-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22238368</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 2013 Jan 1;119(1):7-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22736407</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2012 Dec;23(12):3007-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22865781</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Chemother Res Pract. 2012;2012:743193</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23320171</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2013 Aug 15;73(16):5053-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23794705</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast. 2014 Apr;23(2):128-136</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24360619</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Mol Med (Berl). 2014 Jul;92(7):709-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24811491</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2014 May 21;9(5):e97622</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24849787</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Sci. 2014 Jul 11;15(7):12323-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25019344</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2014 Dec 1;74(23):6737-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25411347</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2015 Sep 1;21(17):3995-4003</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26015514</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Gastroenterol Rep (Oxf). 2015 Nov;3(4):316-29</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26510453</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 May 31;7(22):32247-73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27086914</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Rep. 2017 Feb;37(2):647-656</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27959446</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncoimmunology. 2017 Mar 10;6(3):e1267891</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28405494</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomedicines. 2015 Jan 15;3(1):46-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28536399</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharmacol. 2017 Sep 5;810:100-111</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28625568</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Genomics. 2018 Feb 13;19(1):137</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29433432</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Elife. 2018 May 01;7:</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29712619</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nutrients. 2018 May 06;10(5):null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29734791</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 1987 Jan 9;235(4785):177-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">3798106</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'